Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi S&P 500 Equal Weight ESG UCITS ETF EUR Hedged Acc

MWOQ · IE000M86QRT4 · class UCITS ETF EUR Hedged Acc · EUR · domicile Ireland
Equity · United States · Large cap · Risk parity · Sustainable / ESGEUR-hedged share classSFDR art. 8
Index tracked: S&P 500 Equal Weight ESG+ Index
TER
0.20%+ trans. 0.02%
Fund size
173 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 22 Jun 2023 · costs from the KID as of 2 Sept 2026 · 319 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
This Sub-Fund is passively managed. The Sub-Fund is a financial product that promotes among other characteristics ESG characteristics pursuant to Article 8 of the Disclosure Regulation. The objective of this Sub-Fund is to track the performance of S&P 500 Equal Weight ESG+ Index (the "Index"), and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a net total…

Performance since series start (in euro) — base 100

3 Jul 20238 Sept 2026 · dividends reinvested where declared by the issuer
20242025202614388138
High 143 (26 Aug 2026) · low 88 (27 Oct 2023) · last 138. Past performance is not indicative of future results.

Returns in euro

1 year+13.9%
3 years+41.7%
5 yearsseries too young
10 yearsseries too young
Since series start+38.5%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.25%14.08%
Max drawdown−9.55%−19.08%
Sharpe0.930.66
Sortino1.400.97
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · MWOQ · IE000M86QRT41
RebalixMWOQ · IE000M86QRT4 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+9.99%+9.94%+0.05%
2024+8.65%+8.39%+0.25%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 319 securities · top-10 weight = 4.8%
Top holdingsWeight
MODERNA INC1.0%
CHARLES RIV LAB INT0.5%
SALESFORCE COM0.5%
WORKDAY INC0.4%
GLOBAL PAYMENTS INC0.4%
BIO-TECHNE CORP0.4%
EXPEDIA GROUP INC0.4%
PALO ALTO NETWORKS INC0.4%
REGENERON PHARMACEUTICALS0.4%
SERVICENOW INC0.4%
Countries (% of fund)
United States100.0%
Sectors (% of fund)
Financials18.7%Health Care16.1%Information Technology15.4%Industrials15.3%Consumer Discretionary9.1%

Listing venues

ESMA register (FIRDS) and official exchange lists
MWOQ · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Euronext Paris, Tradegate Exchange, Xetra (Deutsche Börse)
+ 21 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.co.uk/pdfDocuments/kiid/IE000M86QRT4/ENG/GBR
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/IE000M86QRT4/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/IE000M86QRT4/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/IE000M86QRT4
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · MWOQ · IE000M86QRT42